harvardairobotics/FairVision

Dataset Card: Harvard-FairVision

Dataset Summary

Harvard-FairVision is the first large-scale medical fairness dataset with both 2D and 3D imaging data, covering three major eye diseases affecting approximately 380 million people worldwide. It contains 30,000 subjects (10,000 per disease) across Age-Related Macular Degeneration (AMD), Diabetic Retinopathy (DR), and glaucoma, each with paired SLO fundus photos and 3D OCT B-scans and six demographic identity attributes.

This dataset was introduced in the paper: FairVision: Equitable Deep Learning for Eye Disease Screening via Fair Identity Scaling.

Dataset Details

Dataset Description

• —Curated by: Yan Luo, Muhammad Osama Khan, Yu Tian, Min Shi, Zehao Dou, Tobias Elze, Yi Fang, Mengyu Wang
• —License: CC BY-NC-ND 4.0 — non-commercial research only
• —Paper: arXiv:2310.02492
• —Contact: harvardophai@gmail.com, harvardairobotics@gmail.com

Dataset Structure

FairVision
├── AMD
│   ├── Training
│   ├── Validation
│   └── Test
├── data_summary_amd.csv
├── DR
│   ├── Training
│   ├── Validation
│   └── Test
├── data_summary_dr.csv
├── Glaucoma
│   ├── Training
│   ├── Validation
│   └── Test
└── data_summary_glaucoma.csv

Each split folder contains SLO fundus photos (slo_xxxxx.jpg) and NPZ files (data_xxxxx.npz). Per-disease metadata CSVs (data_summary_*.csv) provide race, gender, ethnicity, marital status, age, and preferred language for all subjects.

Data Fields

All NPZ files share the following demographic and imaging fields:

Disease-specific label fields:

Uses

Direct Use

• —Fairness benchmarking for 2D and 3D ophthalmic disease classification across race, gender, and ethnicity
• —Multi-disease fairness analysis (AMD, DR, glaucoma) under a unified framework
• —Development and evaluation of fairness learning methods for medical imaging
• —Comparative study of 2D vs. 3D model fairness in clinical AI

Out-of-Scope Use

Clinical decisions, patient care, or any commercial application. This dataset shall not be used for clinical decisions at any time.

Access

The "Harvard" designation indicates the dataset originates from the Department of Ophthalmology at Harvard Medical School. It does not imply endorsement, sponsorship, or legal responsibility by Harvard University or Harvard Medical School.

Citation

BibTeX:

@misc{luo2024fairvisionequitabledeeplearning,
  title={FairVision: Equitable Deep Learning for Eye Disease Screening via Fair Identity Scaling},
  author={Yan Luo and Muhammad Osama Khan and Yu Tian and Min Shi and Zehao Dou and Tobias Elze and Yi Fang and Mengyu Wang},
  year={2024},
  eprint={2310.02492},
  archivePrefix={arXiv},
  primaryClass={cs.CV},
  url={https://arxiv.org/abs/2310.02492}
}

APA:

Luo, Y., Khan, M. O., Tian, Y., Shi, M., Dou, Z., Elze, T., Fang, Y., & Wang, M. (2024). FairVision: Equitable Deep Learning for Eye Disease Screening via Fair Identity Scaling. arXiv preprint arXiv:2310.02492.